A Cost-Effectiveness Analysis of Vaccination for Prevention of Herpes Zoster and Related Complications: Input for National Recommendations
作者： Lisa A. Prosser , Rafael Harpaz , Angela M. Rose , Acham Gebremariam , Angela Guo
DOI: 10.7326/M18-2347
关键词: Adverse effect 、 Shingles 、 Pediatrics 、 Cost-effectiveness analysis 、 Vaccination 、 Randomized controlled trial 、 Zoster vaccine 、 Medicine 、 Quality-adjusted life year 、 Clinical trial
摘要: A new herpes zoster subunit vaccine, recombinant was approved in 2017 to prevent shingles and complications. This analysis evaluates the cost-effectiveness of that vaccine.
sci-hub.st 参考文章(45)
H. F. Tseng, A. Liu, L. Sy, S. M. Marcy, B. Fireman, E. Weintraub, J. Baggs, S. Weinmann, R. Baxter, J. Nordin, M. F. Daley, L. Jackson, S. J. Jacobsen, , Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study. Journal of Internal Medicine. ,vol. 271, pp. 510- 520 ,(2012) , 10.1111/J.1365-2796.2011.02474.X
Ralph P Insinga, Robbin F Itzler, James M Pellissier, Acute/Subacute Herpes Zoster PharmacoEconomics. ,vol. 25, pp. 155- 169 ,(2007) , 10.2165/00019053-200725020-00007
Puneet K. Singhal, Charles Makin, James Pellissier, Lina Sy, Ron White, Patricia Saddier, Work and productivity loss related to herpes zoster Journal of Medical Economics. ,vol. 14, pp. 639- 645 ,(2011) , 10.3111/13696998.2011.607482
Barbara P. Yawn, Peter C. Wollan, Marge J. Kurland, Jennifer L. St. Sauver, Patricia Saddier, Herpes Zoster Recurrences More Frequent Than Previously Reported Mayo Clinic Proceedings. ,vol. 86, pp. 88- 93 ,(2011) , 10.4065/MCP.2010.0618
Barbara P. Yawn, Peter C. Wollan, Jennifer L. St. Sauver, Linda C. Butterfield, Herpes Zoster--Eye Complications: Rates and Trends Mayo Clinic proceedings. Mayo Clinic. ,vol. 88, pp. 562- 570 ,(2013) , 10.1016/J.MAYOCP.2013.03.014
Jessica Leung, Rafael Harpaz, Noelle-Angelique Molinari, Aisha Jumaan, Fangjun Zhou, Herpes Zoster Incidence Among Insured Persons in the United States, 1993–2006: Evaluation of Impact of Varicella Vaccination Clinical Infectious Diseases. ,vol. 52, pp. 332- 340 ,(2011) , 10.1093/CID/CIQ077
Barbara P. Yawn, Robbin F. Itzler, Peter C. Wollan, James M. Pellissier, Lina S. Sy, Patricia Saddier, Health care utilization and cost burden of herpes zoster in a community population. Mayo Clinic proceedings. ,vol. 84, pp. 787- 794 ,(2009) , 10.4065/84.9.787
Himal Lal, Anthony L Cunningham, Olivier Godeaux, Roman Chlibek, Javier Diez-Domingo, Shinn-Jang Hwang, Myron J Levin, Janet E McElhaney, Airi Poder, Joan Puig-Barberà, Timo Vesikari, Daisuke Watanabe, Lily Weckx, Toufik Zahaf, Thomas C Heineman, None, Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults The New England Journal of Medicine. ,vol. 372, pp. 2087- 2096 ,(2015) , 10.1056/NEJMOA1501184
R. T. Chen, J. W. Glasser, P. H. Rhodes, R. L. Davis, W. E. Barlow, R. S. Thompson, J. P. Mullooly, S. B. Black, H. R. Shinefield, C. M. Vadheim, S. M. Marcy, J. I. Ward, R. P. Wise, S. G. Wassilak, S. C. Hadler, the Vaccine Safety Datalink Team, Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States Pediatrics. ,vol. 99, pp. 765- 773 ,(1997) , 10.1542/PEDS.99.6.765
James G Donahue, Peter W Choo, JoAnn E Manson, Richard Platt, The Incidence of Herpes Zoster Archives of Internal Medicine. ,vol. 155, pp. 1605- 1609 ,(1995) , 10.1001/ARCHINTE.1995.00430150071008